Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

97 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Reducing the Antigen Prevalence Target Threshold for Stopping and Restarting Mass Drug Administration for Lymphatic Filariasis Elimination: A Model-Based Cost-effectiveness Simulation in Tanzania, India and Haiti.
Antony Oliver MC, Graham M, Gass KM, Medley GF, Clark J, Davis EL, Reimer LJ, King JD, Pouwels KB, Hollingsworth TD. Antony Oliver MC, et al. Among authors: pouwels kb. Clin Infect Dis. 2024 Apr 25;78(Supplement_2):S160-S168. doi: 10.1093/cid/ciae108. Clin Infect Dis. 2024. PMID: 38662697 Free PMC article.
Estimating the Effect of Healthcare-Associated Infections on Excess Length of Hospital Stay Using Inverse Probability-Weighted Survival Curves.
Pouwels KB, Vansteelandt S, Batra R, Edgeworth J, Wordsworth S, Robotham JV; Improving the uptake and SusTainability of Effective interventions to promote Prudent antibiotic Use and Primary care (STEP-UP) Team. Pouwels KB, et al. Clin Infect Dis. 2020 Dec 3;71(9):e415-e420. doi: 10.1093/cid/ciaa136. Clin Infect Dis. 2020. PMID: 32047916 Free PMC article.
Costs-effectiveness and cost components of pharmaceutical and non-pharmaceutical interventions affecting antibiotic resistance outcomes in hospital patients: a systematic literature review.
Allel K, Hernández-Leal MJ, Naylor NR, Undurraga EA, Abou Jaoude GJ, Bhandari P, Flanagan E, Haghparast-Bidgoli H, Pouwels KB, Yakob L. Allel K, et al. Among authors: pouwels kb. BMJ Glob Health. 2024 Feb 29;9(2):e013205. doi: 10.1136/bmjgh-2023-013205. BMJ Glob Health. 2024. PMID: 38423548 Free PMC article.
Excess resource use and cost of drug-resistant infections for six key pathogens in Europe: a systematic review and Bayesian meta-analysis.
Kingston R, Vella V, Pouwels KB, Schmidt JE, Abdelatif El-Abasiri RA, Reyna-Villasmil E, Hassoun-Kheir N, Harbarth S, Rodríguez-Baño J, Tacconelli E, Arieti F, Gladstone BP, de Kraker MEA, Naylor NR, Robotham JV; PrIMAVeRa Work Package 1. Kingston R, et al. Among authors: pouwels kb. Clin Microbiol Infect. 2024 Mar;30 Suppl 1:S26-S36. doi: 10.1016/j.cmi.2023.12.013. Epub 2023 Dec 19. Clin Microbiol Infect. 2024. PMID: 38128781 Free article. Review.
A systematic review on the excess health risk of antibiotic-resistant bloodstream infections for six key pathogens in Europe.
Hassoun-Kheir N, Guedes M, Ngo Nsoga MT, Argante L, Arieti F, Gladstone BP, Kingston R, Naylor NR, Pezzani MD, Pouwels KB, Robotham JV, Rodríguez-Baño J, Tacconelli E, Vella V, Harbarth S, de Kraker MEA; PrIMAVeRa Workpackage 1. Hassoun-Kheir N, et al. Among authors: pouwels kb. Clin Microbiol Infect. 2024 Mar;30 Suppl 1:S14-S25. doi: 10.1016/j.cmi.2023.09.001. Epub 2023 Oct 4. Clin Microbiol Infect. 2024. PMID: 37802750 Free article. Review.
Bleeding risk in patients prescribed dual antiplatelet therapy and triple therapy after coronary interventions: the ADAPTT retrospective population-based cohort studies.
Harris J, Pouwels KB, Johnson T, Sterne J, Pithara C, Mahadevan K, Reeves B, Benedetto U, Loke Y, Lasserson D, Doble B, Hopewell-Kelly N, Redwood S, Wordsworth S, Mumford A, Rogers C, Pufulete M. Harris J, et al. Among authors: pouwels kb. Health Technol Assess. 2023 May;27(8):1-257. doi: 10.3310/MNJY9014. Health Technol Assess. 2023. PMID: 37435838 Free PMC article.
97 results